Methods |
Women 'randomly allocated' to 4 groups. Method of randomisation not reported |
Participants |
543 women (aged 18‐47 years old) attending the outpatient clinic of the No. 477 Military Hospital, China. Women had regular menstrual periods and unprotected intercourse within 72 h of attending the clinic |
Interventions |
Mife (single dose) 100 mg vs Mife 50 mg vs Mife 25 mg vs Mife 10 mg, orally |
Outcomes |
Observed number of pregnancies, side effects and changes in menstrual pattern |
Notes |
No mention of post‐randomisation exclusion and loss to follow‐up
Observed pregnancy/expected pregnancy/total number of women: Mife 100 mg 0/13/120; Mife 50 mg 0/16/147; Mife 25 mg 2/14/136; Mife 10 mg 8/14/140
|
Risk of bias |
Bias |
Authors' judgement |
Support for judgement |
Random sequence generation (selection bias) |
Unclear risk |
Mentioned randomisation but description not adequate |
Allocation concealment (selection bias) |
Unclear risk |
Method of allocation concealment not mentioned |
Blinding (performance bias and detection bias) All outcomes |
Unclear risk |
Not mentioned |
Incomplete outcome data (attrition bias) All outcomes |
Unclear risk |
Any losses to follow‐up or exclusion were not reported |
Selective reporting (reporting bias) |
Low risk |
Planned outcome of pregnancy rate was reported |
Other bias |
Low risk |
None detected |